Cend Therapeutics

DrugCendR Inc. is a biopharmaceutical company dedicated to developing the next generation of cancer therapies, which aim to overcome the barriers to drug delivery to solid tumors. The novel drug delivery platform has high specificity in cancer tissues, thus holding the potential to maximize efficacy while minimizing the toxicity and side effects commonly associated with cancer treatments.